Growth Metrics

Vivos (RDGL) Net Cash Flow Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Vivos - - -3,105.00 -154.34%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -154.34%
Sep 30, 2025 9.44%
Jun 30, 2025 -270.96%
Mar 31, 2025 575.28%
Dec 31, 2024 1,693.53%
Sep 30, 2024 -138.89%
Jun 30, 2024 212.49%
Mar 31, 2024 24.58%
Dec 31, 2023 119.68%
Sep 30, 2023 25.11%
Jun 30, 2023 -83.70%
Mar 31, 2023 23.59%
Dec 31, 2022 25.97%
Sep 30, 2022 -58.90%
Jun 30, 2022 50.71%
Mar 31, 2022 -123.90%
Dec 31, 2021 -142.81%
Sep 30, 2021 23.87%
Jun 30, 2021 -242.37%
Mar 31, 2021 10,558.09%
Dec 31, 2020 743.30%
Sep 30, 2020 -255.91%
Jun 30, 2020 832.57%
Mar 31, 2020 -142.37%
Dec 31, 2019 -2,614.69%
Jun 30, 2019 -207,943.75%
Mar 31, 2019 537.24%
Dec 31, 2018 139.83%
Jun 30, 2018 -100.00%
Mar 31, 2018 -98.16%
Dec 31, 2017 99.58%
Sep 30, 2017 -110.55%
Jun 30, 2017 239.55%
Mar 31, 2017 -106.08%
Dec 31, 2016 -2,001.57%
Sep 30, 2016 17,575.35%
Jun 30, 2016 -1,143.35%
Mar 31, 2016 2,919.50%
Dec 31, 2015 53,403.11%
Sep 30, 2015 84.90%
Jun 30, 2015 -29.33%
Mar 31, 2015 -97.51%
Dec 31, 2014 98.77%
Sep 30, 2014 -748.39%
Jun 30, 2014 155.51%
Mar 31, 2014 49.96%
Dec 31, 2013 36.00%
Sep 30, 2013 -42.65%
Jun 30, 2013 -11,046.65%
Mar 31, 2013 255.63%
Dec 31, 2012 -220.84%
Sep 30, 2012 148.06%
Jun 30, 2012 100.43%
Mar 31, 2012 91.40%
Dec 31, 2011 101.90%
Sep 30, 2011 -97.32%